The Landscape of Pediatric Procedural Sedation in the United Kingdom and Irish Emergency Departments; an International Survey Study
Abstract
Approximately 250 000 children undergo pediatric procedural sedation (PPS) in Emergency Departments (ED) in the United Kingdom and Ireland annually. PPS practice in our setting has not been described as fully as other high‐income countries. We aimed to evaluate PPS in EDs in the United Kingdom and Ireland. An online survey was distributed through Paediatric Emergency Research in the UK and Ireland (PERUKI), in June 2020. One respondent per ED completed the survey, including questions on agents, fasting, training, and governance. Of 72 PERUKI sites, 61 (85%) responded, of which PPS was performed in 50 (82%). Internal training packages existed in under half (22/50, 44.0%). Most had a guideline (43/50; 86.0%) and documentation proforma (39/50; 78.0%). Audit databases existed in 24/50 (48.0%). Intravenous ketamine was the most common agent (43/50; 86%), followed by variable concentration nitrous oxide (13/50; 26%). Fasting practices varied widely across sites and agents. We have demonstrated widespread PPS use, but non‐standardized practice. This leads to potential issues of risk and variability across agents, highlighting a need for a sedation package in the United Kingdom and Ireland to standardize practice and data collection. We propose development of a prospective ED sedation registry in the United Kingdom and Ireland to facilitate data collection to support research within this area.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.